Longeveron Inc. Reports Director/Officer Changes & Financials
Ticker: LGVN · Form: 8-K · Filed: Oct 1, 2025 · CIK: 1721484
Sentiment: neutral
Topics: management-change, corporate-governance, filings
TL;DR
Longeveron's 8-K: Board shakeup and financial updates filed.
AI Summary
Longeveron Inc. filed an 8-K on October 1, 2025, reporting events as of September 25, 2025. The filing pertains to the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. It also includes financial statements and exhibits.
Why It Matters
This filing indicates potential shifts in the company's leadership and governance structure, which could impact strategic direction and operational oversight.
Risk Assessment
Risk Level: medium — Changes in directors or officers can signal internal shifts that may affect company strategy or stability.
Key Players & Entities
- Longeveron Inc. (company) — Registrant
- September 25, 2025 (date) — Date of earliest event reported
- October 1, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
- Miami, Florida (location) — Principal executive offices
FAQ
What specific roles have seen departures or appointments?
The filing indicates changes related to the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers' but does not specify the names or exact roles within this excerpt.
When was the earliest event reported in this filing?
The earliest event reported was on September 25, 2025.
What is Longeveron Inc.'s state of incorporation?
Longeveron Inc. is incorporated in Delaware.
What is the company's principal executive office address?
The principal executive offices are located at 1951 NW 7th Avenue, Suite 520, Miami, Florida 33136.
What other items are included in this 8-K filing besides personnel changes?
The filing also includes 'Financial Statements and Exhibits'.
Filing Stats: 571 words · 2 min read · ~2 pages · Grade level 11 · Accepted 2025-10-01 16:29:44
Key Financial Figures
- $0.001 — hich registered Class A Common Stock, $0.001 par value per share LGVN The Nasdaq
Filing Documents
- ea0259742-8k_longever.htm (8-K) — 26KB
- ea025974201ex99-1_longever.htm (EX-99.1) — 7KB
- ex99-1_001.jpg (GRAPHIC) — 3KB
- 0001213900-25-094710.txt ( ) — 205KB
- lgvn-20250925.xsd (EX-101.SCH) — 3KB
- lgvn-20250925_lab.xml (EX-101.LAB) — 33KB
- lgvn-20250925_pre.xml (EX-101.PRE) — 22KB
- ea0259742-8k_longever_htm.xml (XML) — 4KB
02. Departure
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 25, 2025, the Board of Directors (the "Board") of Longeveron Inc. (the "Company") approved Dr. George Paletta, age 63, to fill a current vacancy on the Board as a Class I director, effective October 1, 2025. In connection with his appointment to the Board, Dr. Paletta will receive compensation consistent with the Board's current compensation arrangement for Board members, pro-rated in accordance with his service time for the year. The Company also has entered into an indemnification agreement with Dr. Paletta in the same form as the indemnification agreements entered into with each of its directors. There are no arrangements or understandings between Dr. Paletta and any other person pursuant to which he was selected as a director, and there have been no transactions since the beginning of the Company's last fiscal year, or currently proposed, regarding Dr. Paletta that are required to be disclosed by Item 404(a) of Regulation S-K. A copy of the Company's press release announcing the appointment of Dr. Paletta is attached as Exhibit 99.1 to this Current Report on Form 8-K.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release issued by the Company October 1, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LONGEVERON INC. Date: October 1, 2025 /s/ Than Powell Name: Than Powell Title: Chief Executive Officer 2